Ventoxen 100 mg Tablet

Product Details

Ventoxen 100 mg Tablet contains venetoclax, also known as  Venclexta and Venclyxto is a targeted therapy used for the treatment of certain blood cancers. It works as a BCL-2 inhibitor, promoting cancer cell death by restoring the body’s ability to clear malignant cells.

Uses

• Chronic Lymphocytic Leukemia (CLL): Effective in treating CLL, including in patients with high-risk mutations.
• Small Lymphocytic Lymphoma (SLL): Used in treating SLL, which has similar characteristics to CLL.
• Acute Myeloid Leukemia (AML) (for certain patients): Often used in combination with other treatments.

How Ventoxen Works

Venetoclax inhibits BCL-2, a protein that prevents cancer cell death. By blocking this protein, Ventoxen helps induce apoptosis (programmed cell death), reducing the number of cancer cells.

Common Side Effects

• Nausea, vomiting, or diarrhea
• Fatigue and weakness
• Low blood cell counts (e.g., neutropenia, anemia)
• Fever
• Upper respiratory tract infections

Serious Side Effects (Seek Immediate Medical Attention)

• Tumor lysis syndrome (TLS), a rapid breakdown of cancer cells leading to metabolic complications
• Severe infections
• Liver enzyme changes
• Severe anemia or bleeding

Key Features

• Contains venetoclax, a potent BCL-2 inhibitor.
• Targeted therapy for chronic lymphocytic leukemia and small lymphocytic lymphoma.
• Often used in combination regimens for optimized treatment.
• Helps promote programmed cell death in cancerous cells.

Frequently Asked Questions (FAQ)

1. How should I take Ventoxen 100 mg Tablet?
   Follow your doctor’s instructions. Typically, venetoclax is taken with food and plenty of water to minimize gastrointestinal side effects.
2. Is monitoring necessary while on Ventoxen?
   Yes, patients need regular blood tests and monitoring for tumor lysis syndrome (TLS) and other complications during treatment.
3. Can Ventoxen be taken during pregnancy?
   Venetoclax is not recommended during pregnancy due to potential harm to the fetus. Consult with your healthcare provider for options.

References

1. FDA – Venetoclax Information
   Available from: https://www.venclexta.com/
2. Clinical Guidelines – Blood Cancer Treatments
   Available from: https://en.wikipedia.org/wiki/Venetoclax